Open opportunities › Grants

342 open health grants for small businesses

Federal grant opportunities on Grants.gov in health, open to small businesses, still open, soonest deadline first.

Updated Oct 18, 2026 · source: Grants.gov
National Institutes of Health

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)

PAR-25-155 · Up to $50K

Due Oct 19, 2026Official listing on Grants.gov ↗
National Institutes of Health

Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)

RFA-DE-27-001 · $1M total program funding

Due Oct 19, 2026Official listing on Grants.gov ↗
National Institutes of Health

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

RFA-CA-27-021 · Up to $600K

Due Oct 19, 2026Official listing on Grants.gov ↗
National Institutes of Health

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

RFA-CA-27-020 · Up to $600K

Due Oct 19, 2026Official listing on Grants.gov ↗
National Institutes of Health

PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)

RFA-RM-27-012

Due Oct 19, 2026Official listing on Grants.gov ↗

Only want the ones that fit you? We screen every new Grants.gov listing and email you the 3–7 worth your time.

Get these picks by email
National Institutes of Health

Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)

RFA-RM-27-013

Due Oct 19, 2026Official listing on Grants.gov ↗
National Institutes of Health

Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)

RFA-DK-27-120 · Up to $750K

Due Oct 20, 2026Official listing on Grants.gov ↗
National Institutes of Health

Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)

RFA-MH-27-140 · $1.5M total program funding

Due Oct 22, 2026Official listing on Grants.gov ↗
Centers for Disease Control - NCBDDD

Long-term health outcomes of people living with spina bifida

CDC-RFA-DD-26-0222 · Up to $300K

Due Oct 26, 2026Official listing on Grants.gov ↗
National Institutes of Health

GREGoRi Technology Integration Center (U01, Clinical Trials Optional)

RFA-HG-27-012 · Up to $2.3M

Due Oct 30, 2026Official listing on Grants.gov ↗
National Institutes of Health

GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)

RFA-HG-27-011 · Up to $1.3M

Due Oct 30, 2026Official listing on Grants.gov ↗
National Institutes of Health

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

PAR-24-280

Due Nov 2, 2026Official listing on Grants.gov ↗
National Institutes of Health

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

PAR-24-279

Due Nov 2, 2026Official listing on Grants.gov ↗
National Institutes of Health

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

PAR-25-255

Due Nov 5, 2026Official listing on Grants.gov ↗
National Institutes of Health

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

PAR-25-095 · Up to $350K

Due Nov 6, 2026Official listing on Grants.gov ↗
National Institutes of Health

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

RFA-NS-26-001 · $40M total program funding

Due Nov 10, 2026Official listing on Grants.gov ↗
National Institutes of Health

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-27-002 · Up to $300K

Due Nov 10, 2026Official listing on Grants.gov ↗
National Institutes of Health

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

RFA-CA-27-001 · Up to $150K

Due Nov 10, 2026Official listing on Grants.gov ↗
National Institutes of Health

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

RFA-AI-27-005 · $18M total program funding

Due Nov 10, 2026Official listing on Grants.gov ↗
National Institutes of Health

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

RFA-AI-27-002 · $10M total program funding

Due Nov 10, 2026Official listing on Grants.gov ↗
National Institutes of Health

Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

RFA-AG-27-010 · $2.5M total program funding

Due Nov 10, 2026Official listing on Grants.gov ↗
National Institutes of Health

Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)

RFA-RM-27-024 · Up to $100K

Due Nov 10, 2026Official listing on Grants.gov ↗
National Institutes of Health

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

PAR-25-271 · $350K total program funding

Due Nov 13, 2026Official listing on Grants.gov ↗
National Institutes of Health

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

PAR-25-269 · Up to $350K

Due Nov 13, 2026Official listing on Grants.gov ↗
National Institutes of Health

NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

PAR-24-089 · Up to $750K

Due Nov 13, 2026Official listing on Grants.gov ↗
National Institutes of Health

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

PAR-25-270 · Up to $1.1M

Due Nov 13, 2026Official listing on Grants.gov ↗
National Institutes of Health

Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)

PAR-25-370 · Up to $50K

Due Nov 16, 2026Official listing on Grants.gov ↗
National Institutes of Health

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

PAR-25-274

Due Nov 17, 2026Official listing on Grants.gov ↗
National Institutes of Health

Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)

PAR-25-268

Due Nov 17, 2026Official listing on Grants.gov ↗
National Institutes of Health

NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)

PAR-25-267 · Up to $350K

Due Nov 17, 2026Official listing on Grants.gov ↗
National Institutes of Health

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

PAR-25-158

Due Nov 17, 2026Official listing on Grants.gov ↗
National Institutes of Health

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

PAR-25-096 · Up to $200K

Due Nov 17, 2026Official listing on Grants.gov ↗
National Institutes of Health

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

PAR-25-371

Due Nov 18, 2026Official listing on Grants.gov ↗
National Institutes of Health

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

PAR-25-369

Due Nov 18, 2026Official listing on Grants.gov ↗
National Institutes of Health

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

PAR-25-052

Due Nov 19, 2026Official listing on Grants.gov ↗
National Institutes of Health

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

PAR-25-226

Due Nov 19, 2026Official listing on Grants.gov ↗
National Institutes of Health

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

RFA-RM-27-007 · $6M total program funding

Due Nov 23, 2026Official listing on Grants.gov ↗
National Institutes of Health

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

RFA-RM-27-016

Due Nov 23, 2026Official listing on Grants.gov ↗

Showing the 40 soonest deadlines of 342. Search all on Grants.gov.

Related: open health grants for nonprofits open research and development grants for nonprofits open education grants for nonprofits open social services grants for nonprofits open environment grants for nonprofits open justice and public safety grants for nonprofits open food and nutrition grants for nonprofits open agriculture grants for nonprofits